Page last updated: 2024-10-25

citalopram and Heart Diseases

citalopram has been researched along with Heart Diseases in 10 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research Excerpts

ExcerptRelevanceReference
"Citalopram daily doses >40 mg were associated with lower risks of ventricular arrhythmia (adjusted hazard ratio=0."3.79Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. ( Blow, FC; Bohnert, AS; Ganoczy, D; Kales, HC; Nallamothu, BK; Pfeiffer, PN; Zivin, K, 2013)
"Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is widely used in clinical practice."2.49Citalopram and cardiac toxicity. ( Cooke, MJ; Waring, WS, 2013)
"Hydroxychloroquine has been widely prescribed to treat patients with COVID-19 pneumonia."1.62Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications. ( Ali, N; Aslam, W; Lamb, CR, 2021)
"Information on rare adverse effects is often limited when a medication is initially approved for marketing."1.56Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies. ( Bhasale, A; Fabbri, A; Hooimeyer, A; McEwin, E; Mintzes, B; Mohammad, A; Perry, L, 2020)
"The aim of the present study was to compare cardiovascular and/or cardiotoxic effects of eight anti-depressants (imipramine, chlorimipramine, amitriptyline, nortriptyline , doxepin, maprotiline, mianserin and citalopram) in anaesthetized cats after oral dosing and in conscious rabbits after intravenous infusion."1.27Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels. ( Boeck, V; Fredricson Overø, K; Jørgensen, A, 1984)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's2 (20.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Hooimeyer, A1
Bhasale, A1
Perry, L1
Fabbri, A1
Mohammad, A1
McEwin, E1
Mintzes, B1
Aslam, W1
Lamb, CR1
Ali, N1
Zivin, K1
Pfeiffer, PN1
Bohnert, AS1
Ganoczy, D1
Blow, FC1
Nallamothu, BK1
Kales, HC1
Cooke, MJ1
Waring, WS1
Alexopoulos, GS1
Kiosses, DN1
Murphy, C1
Heo, M1
Balon, R1
de Jonge, P1
Honig, A1
van Melle, JP1
Schene, AH1
Kuyper, AM1
Tulner, D1
Schins, A1
Ormel, J1
Aström-Lilja, C1
Odeberg, JM1
Ekman, E1
Hägg, S1
Boeck, V1
Jørgensen, A1
Fredricson Overø, K1
Rasmussen, SL1
Overø, KF1
Tanghøj, P1

Reviews

2 reviews available for citalopram and Heart Diseases

ArticleYear
Citalopram and cardiac toxicity.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:4

    Topics: Animals; Citalopram; Dose-Response Relationship, Drug; Heart Diseases; Humans; Long QT Syndrome; Sel

2013
Mood, anxiety, and physical illness: body and mind, or mind and body?
    Depression and anxiety, 2006, Volume: 23, Issue:6

    Topics: Anxiety Disorders; Autoimmune Diseases; Citalopram; Comorbidity; Health Status; Heart Diseases; Huma

2006

Trials

2 trials available for citalopram and Heart Diseases

ArticleYear
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
    The American journal of psychiatry, 2007, Volume: 164, Issue:9

    Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive

2007
Cardiac safety of citalopram: prospective trials and retrospective analyses.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Electrocardiography;

1999

Other Studies

6 other studies available for citalopram and Heart Diseases

ArticleYear
Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies.
    Pharmacology research & perspectives, 2020, Volume: 8, Issue:6

    Topics: Australia; Canada; Citalopram; Databases, Factual; Drug and Narcotic Control; Drug-Related Side Effe

2020
Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
    BMJ case reports, 2021, Mar-24, Volume: 14, Issue:3

    Topics: Aged; Anti-Infective Agents; Citalopram; COVID-19 Drug Treatment; Dexamethasone; Donepezil; Drug The

2021
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg.
    The American journal of psychiatry, 2013, Volume: 170, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Citalopram; Depressive Disorder; Female; Heart

2013
Executive dysfunction, heart disease burden, and remission of geriatric depression.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:12

    Topics: Aged; Antidepressive Agents; Citalopram; Cognition Disorders; Cost of Illness; Depressive Disorder,

2004
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
    Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:6

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Ca

2008
Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels.
    Psychopharmacology, 1984, Volume: 82, Issue:4

    Topics: Anesthesia; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiac Output; Cardio

1984